Skip to main content
MITI
OTC Technology

Mitesco Adds $180K in Toxic Convertible Debt and Issues 1M Shares Amid Cash Crunch

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.026
Mkt Cap
$538.802K
52W Low
$0.023
52W High
$0.398
52W Position info
10% above low
Off High info
94% below high
Rel. Volume info
2.5× avg
Market data snapshot near publication time

MITI is trading near its 52-week low of $0.023 (10% above the low) on elevated volume (2.5× avg).

Summary

Mitesco raised $180,000 in new debt with steep discounts and issued 1 million shares for services, extending its runway but adding significant dilution risk.


Key Events · Financing and Capital Events · MITI

  • New Convertible Note from AJB

    AJB Capital Investments provided $20,000 in cash for a $22,000 note (10% OID) maturing February 2, 2027. Conversion is only available after a maturity payment default at 70% of the 5-day VWAP, with a 1.8 million share reserve.

  • High-Cost Term Notes

    C/M Capital Master Fund LP lent $100,000 and WVP lent $60,000, each with a 20% original issue discount and 60-day term. The notes require 100% of net proceeds from any future financing to be applied to repayment.

  • Share Issuance for Services

    The company agreed to issue 1,000,000 restricted common shares to a consulting group for software development, adding to the recent 17.1 million restricted share authorization.

  • Bridge Note Extensions

    Holders of $200,000 in 2025 Bridge Notes agreed to extend maturities: $78,000 to September 1, 2026 and the remainder to December 31, 2026.


Analysis · MITI · Technology

With only $8,000 in cash and $22.4M in current liabilities, Mitesco has taken on $180,000 in new high-cost debt and issued 1 million restricted shares for software development. The AJB note carries a 10% original issue discount and converts at a 30% discount to market only upon default, while the C/M and WVP notes carry a 20% OID and mandatory prepayment from any future financing. These terms are highly dilutive and reflect severe financing distress.

At the time of this filing, MITI was trading at $0.03 on OTC in the Technology sector, with a market capitalization of approximately $538.8K. The 52-week trading range was $0.02 to $0.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MITI - Latest Insights

MITI
Aug 17, 2026, 4:29 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0263
Real-time Price: $0.02573 info
Change: -$0.00057 (-2%) info
Market Cap: $538.802K info
MITI
Aug 10, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.0343
Real-time Price: $0.02573 info
Change: -$0.00857 (-25%) info
Market Cap: $538.802K info
MITI
Aug 04, 2026, 7:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.035
Real-time Price: $0.02573 info
Change: -$0.00927 (-26%) info
Market Cap: $538.802K info
MITI
Jul 21, 2026, 5:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0975
Real-time Price: $0.02573 info
Change: -$0.07177 (-74%) info
Market Cap: $538.802K info
MITI
Jul 09, 2026, 4:13 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.070
Real-time Price: $0.02573 info
Change: -$0.04427 (-63%) info
Market Cap: $538.802K info